Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12621000082808
Ethics application status
Approved
Date submitted
23/11/2020
Date registered
1/02/2021
Date last updated
1/02/2021
Date data sharing statement initially provided
1/02/2021
Type of registration
Prospectively registered
Titles & IDs
Public title
Impact of an mHealth self-help intervention on readmission rates after adult cardiac surgery: a pilot randomised controlled trial.
Query!
Scientific title
Impact of an mHealth self-help intervention on readmission rates after adult cardiac surgery: a pilot randomised controlled trial
Query!
Secondary ID [1]
302851
0
Nil known
Query!
Universal Trial Number (UTN)
U1111-1261-6616
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
cardiac surgery
319831
0
Query!
Condition category
Condition code
Cardiovascular
317773
317773
0
0
Query!
Coronary heart disease
Query!
Surgery
317774
317774
0
0
Query!
Other surgery
Query!
Cardiovascular
318088
318088
0
0
Query!
Other cardiovascular diseases
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
GoShare (the intervention) is a customised care bundle that promotes self-efficacy and self-management behaviours to empower patients to have a more active role in their healthcare.
The care bundle contains a patient narrative library with a series of videos describing patient and carer experiences, in addition to links to reputable on-line resources. The content in the Cardiac Surgery bundle is customised to support adult patients undergoing cardiac surgery that requires a surgical incision on the thorax; either median sternotomy or minimally invasive access via thoracotomy. This bundle provides resources specific to receiving a diagnosis that requires cardiac surgical intervention (5 minutes, 48 seconds), preparing for heart surgery (4 minutes 47 seconds), recovery after heart surgery (5 minutes) and rehabilitation after heart surgery (2 minutes, 37 seconds). The videos are delivered by a mixture of male and female patients representing young to older adults. The patients in the videos do not discuss specifics of surgery or medical management, the focus is on strategies for self-help and self-efficacy in managing the cardiac surgical experience. The information sheets in the bundle link to the Australian Centre for Heart Health, the National Heart Foundation (NHF) and the NHF 'My Heart, My Life' application. The care bundle will be accessible to participants indefinitely.
Adult patients randomised to the intervention will receive a text-message or email link to the online platform prior to undergoing cardiac surgery with a single reminder within 48 hours of discharge from hospital. Usage metrics will be extracted from the GoShare interface to confirm access reminders, assess access frequency, assess access duration and review content items viewed at the time of access. Follow-up phone calls from an expert cardiothoracic nurse will occur at 30, 60 and 90-days after the day of surgery. Each phone call will take approximately 15 to 20 minutes. During the phone call a series of questions will be asked to confirm consent to participate, to confirm whether representation or readmission to hospital has been required, to assess quality of life (EQ5D-5L) and to assess patient activation (PAM).
Query!
Intervention code [1]
319133
0
Behaviour
Query!
Intervention code [2]
319365
0
Rehabilitation
Query!
Comparator / control treatment
The control group will receive usual pre and postoperative care that includes a preoperative phone consultation, attendance at pre-admission clinic for screening and physical assessment, written materials on discharge from hospital and a 30-day follow up phone call.
Written materials are site specific materials that are readily available to all patients.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
325798
0
All patients will be asked at the 30-day follow-up phone call if they have represented to hospital. Patients in the intervention group will be asked the same questions at the 60 and 90-day follow-up phone calls. All patients will have representation confirmed via cross validation with two sources; the Australian and new Zealand Society of Cardiothoracic Surgery Clinical Quality Registry and the Victorian Agency for Health Information (VAHI).
Query!
Assessment method [1]
325798
0
Query!
Timepoint [1]
325798
0
30-days, 60-days, 90-days and 12-months after surgery
Query!
Primary outcome [2]
325799
0
All patients will be asked at the 30-day follow-up phone call if they have required readmission to hospital. Patients in the intervention group will be asked the same questions at the 60 and 90-day follow-up phone calls. All patients will have readmission confirmed via cross validation with two sources; the Australian and new Zealand Society of Cardiothoracic Surgery Clinical Quality Registry and the Victorian Agency for Health Information (VAHI).
Query!
Assessment method [2]
325799
0
Query!
Timepoint [2]
325799
0
30-days, 60-days, 90-days and 12 months after surgery
Query!
Secondary outcome [1]
389176
0
Care bundle uptake will be determined by reviewing access metrics.
Query!
Assessment method [1]
389176
0
Query!
Timepoint [1]
389176
0
Within 12-months after surgery
Query!
Secondary outcome [2]
389177
0
Knowledge, skill and confidence for self-management as measured by the 13-item PAM (Patient Activation Measure)
Query!
Assessment method [2]
389177
0
Query!
Timepoint [2]
389177
0
30-days, 60-days, 90-days after surgery
Query!
Secondary outcome [3]
389178
0
Health related quality of life as measured by the EQ5D-5L.
Query!
Assessment method [3]
389178
0
Query!
Timepoint [3]
389178
0
30-days, 60-days and 90-days after surgery
Query!
Eligibility
Key inclusion criteria
Adults (> 18 years of age) undergoing elective CABGS, Valve surgery, CABGS and Valve surgery or aortic surgery, discharged home within 30-days, able to understand spoken English and own and use a smartphone.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Adults undergoing thoracic, transplant or non-elective surgery, not discharged within 30-days and unable to communicate in English without an interpreter.
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation involves contacting the holder of the allocation schedule who is off site.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Permuted block randomisation
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
In the Australian context readmission occurs in up to 15% of cardiac surgical patients, with a mean age of 64.4 years, within 30-days of surgery.
To be 95% confident that the readmission rate is within 10%, assuming 15% of the population will be readmitted a total sample size of 49 patients is required.
Frequency of representation, readmission and GoShare metrics will be reported as proportions and the EQ5D-5L and PAM endpoints are scale measures that will also be compared between intervention and control groups. Categorical variables will be analysed using chi-square or two-tailed Fisher’s exact test with appropriate degrees of freedom to test for equality of proportions. Independent samples t-tests (two-tailed) will be used to test for equality of means of continuous variables or the non-parametric equivalent Kruskal-Wallis test. The approach to analysis of repeated measures results from the EQ5D-5L and PAM will be dependent on loss to follow-up and normality of distribution.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/02/2021
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
26/11/2021
Query!
Actual
Query!
Date of last data collection
Anticipated
26/11/2022
Query!
Actual
Query!
Sample size
Target
60
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW,VIC
Query!
Recruitment hospital [1]
18078
0
Royal Melbourne Hospital - City campus - Parkville
Query!
Recruitment hospital [2]
18079
0
Liverpool Hospital - Liverpool
Query!
Recruitment hospital [3]
18080
0
Westmead Hospital - Westmead
Query!
Recruitment postcode(s) [1]
32066
0
3050 - Parkville
Query!
Recruitment postcode(s) [2]
32067
0
2170 - Liverpool
Query!
Recruitment postcode(s) [3]
32068
0
2145 - Westmead
Query!
Funding & Sponsors
Funding source category [1]
307271
0
University
Query!
Name [1]
307271
0
Western Sydney University
Query!
Address [1]
307271
0
161-169 Macquarie St, Parramatta NSW 2150
Query!
Country [1]
307271
0
Australia
Query!
Funding source category [2]
307272
0
Hospital
Query!
Name [2]
307272
0
The Royal Melbourne Hospital
Query!
Address [2]
307272
0
300 Grattan Street, Parkville, VIC 3010
Query!
Country [2]
307272
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
The Royal Melbourne Hospital
Query!
Address
300 Grattan Street, Parkville, VIC 3010
Query!
Country
Australia
Query!
Secondary sponsor category [1]
307895
0
University
Query!
Name [1]
307895
0
Western Sydney University
Query!
Address [1]
307895
0
161-169 Macquarie St, Parramatta NSW 2150
Query!
Country [1]
307895
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
307368
0
Melbourne Health HREC
Query!
Ethics committee address [1]
307368
0
300 Grattan Street, Parkville, VIC 3010
Query!
Ethics committee country [1]
307368
0
Australia
Query!
Date submitted for ethics approval [1]
307368
0
27/10/2020
Query!
Approval date [1]
307368
0
17/11/2020
Query!
Ethics approval number [1]
307368
0
HREC/69278/MH-2020
Query!
Summary
Brief summary
Patients requiring cardiac surgery during COVID-19 are at greater risk of death and adverse events. Smartphone based support could help to improve outcomes during this pandemic. Health services have been drastically reduced; preadmission clinics are limited or closed, telehealth services are inadequate, elective cardiac surgery is restricted, hospitals are limiting visitors and almost 50% of cardiac rehabilitation services have ceased. Evidence for strategies that optimise post cardiac surgery recovery is sparse. In this study the effect of a GoShare mHealth (smartphone) intervention on recovery after adult cardiac surgery during COVID-19 will be evaluated. Interventions using smartphone technology have proven effectiveness for a range of cardiovascular conditions under normal conditions. COVID-19 has created extraordinary circumstances that will persist for some time. We hypothesise that the GoShare mHealth intervention will improve (intermediate and ongoing) patient recoveryafter cardiac surgery, reducing representation and readmission rates when compared to usual care during COVID-19. This study provides an opportunity to improve patient outcome and experience for adults undergoing cardiac surgery throughout and beyond the COVID-19 pandemic in Australia. This study aims to reduce representation and readmission, by empowering patients as end-users with strategies for self-help.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
106986
0
Prof Rochelle Wynne
Query!
Address
106986
0
Western Sydney Nursing & Midwifery Research Centre
Blacktown Hospital Clinical School
Marcel Crescent
Blacktown NSW 2148
Query!
Country
106986
0
Australia
Query!
Phone
106986
0
+61 407822988
Query!
Fax
106986
0
Query!
Email
106986
0
[email protected]
Query!
Contact person for public queries
Name
106987
0
Rochelle Wynne
Query!
Address
106987
0
Western Sydney Nursing & Midwifery Research Centre
Blacktown Hospital Clinical School
Marcel Crescent
Blacktown NSW 2148
Query!
Country
106987
0
Australia
Query!
Phone
106987
0
+61 407822988
Query!
Fax
106987
0
Query!
Email
106987
0
[email protected]
Query!
Contact person for scientific queries
Name
106988
0
Rochelle Wynne
Query!
Address
106988
0
Western Sydney Nursing & Midwifery Research Centre
Blacktown Hospital Clinical School
Marcel Crescent
Blacktown NSW 2148
Query!
Country
106988
0
Australia
Query!
Phone
106988
0
+61 407822988
Query!
Fax
106988
0
Query!
Email
106988
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Ethical approval has not been provided to enable public sharing of participant data.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Effect of an mHealth self-help intervention on readmission after adult cardiac surgery: Protocol for a pilot randomized controlled trial.
2022
https://dx.doi.org/10.1111/jan.15104
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF